Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us ![]()
About
IMCAS World CongressIMCAS World Congress
Not Confirmed
Not Confirmed
29-31 January, 2026
IMCAS World CongressIMCAS World Congress
Not Confirmed
Not Confirmed
29-31 January, 2026
34th NZW-Hamburg34th NZW-Hamburg
Not Confirmed
Not Confirmed
30 January-01 February, 2026
List your booth number for exhibitions, ask us
CONTACT DETAILS




Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
IMCAS World CongressIMCAS World Congress
Industry Trade Show
Not Confirmed
29-31 January, 2026
IMCAS World CongressIMCAS World Congress
Industry Trade Show
Not Confirmed
29-31 January, 2026
34th NZW-Hamburg34th NZW-Hamburg
Industry Trade Show
Not Confirmed
30 January-01 February, 2026
Digital content

26 Jan 2026
// BUSINESSWIRE
https://www.businesswire.com/news/home/20260126610526/en/Mirum-Pharmaceuticals-Completes-Acquisition-of-Bluejay-Therapeutics-Expanding-Global-Leadership-in-Rare-Disease

12 Jan 2026
// BUSINESSWIRE
https://www.businesswire.com/news/home/20260112830077/en/Mirum-Pharmaceuticals-Reports-Inducement-Grants-Under-Nasdaq-Listing-Rule-5635c4

12 Jan 2026
// BUSINESSWIRE
https://www.businesswire.com/news/home/20260112142021/en/Mirum-Pharmaceuticals-Announces-Preliminary-Unaudited-2025-Results-Demonstrating-Strong-Commercial-Growth-and-Pipeline-Momentum

09 Jan 2026
// BUSINESSWIRE
https://www.businesswire.com/news/home/20260109046100/en/Enthorin-Therapeutics-Announces-Initiation-of-Phase-II-Clinical-Trial-of-MRM-3379-Formerly-ENT-3379-for-Fragile-X-Syndrome-by-Licensing-Partner-Mirum-Pharmaceuticals

07 Jan 2026
// BUSINESSWIRE
https://www.businesswire.com/news/home/20260107241247/en/Mirum-Pharmaceuticals-to-Present-at-the-44th-Annual-J.P.-Morgan-Healthcare-Conference

19 Dec 2025
// PHARMIWEB
https://www.pharmiweb.com/press-release/2025-12-19/mirum-pharmaceuticals-announces-additional-private-placement-financing-with-tcgx
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE